Edgar G. Engleman
Edgar G. Engleman is a renowned immunologist and pathologist known for his significant contributions to the field of medicine. He is currently serving as a Professor of Pathology and Medicine at Stanford University School of Medicine.
Early Life and Education[edit | edit source]
Edgar G. Engleman was born in New York City. He completed his undergraduate studies at Columbia University, where he developed an interest in biology and chemistry. He then pursued his medical degree from Yale University School of Medicine, where he specialized in immunology and pathology.
Career[edit | edit source]
After completing his medical degree, Engleman joined Stanford University School of Medicine as a faculty member. He has made significant contributions to the field of immunology, particularly in the development of dendritic cell-based cancer immunotherapy. His research has led to the development of several innovative therapies for cancer and other diseases.
Engleman is also the founder of several biotechnology companies, including Dendreon Corporation, which developed the first FDA-approved cancer immunotherapy, and Cellerant Therapeutics, which is developing stem cell and immunotherapy-based treatments for cancer and other diseases.
Research[edit | edit source]
Engleman's research focuses on the role of the immune system in health and disease. He has made significant contributions to our understanding of how the immune system can be harnessed to fight cancer and other diseases. His work on dendritic cells has been particularly influential, leading to the development of new therapies for cancer and other diseases.
Awards and Recognition[edit | edit source]
Engleman has received numerous awards and recognition for his contributions to medicine and science, including the American Association for Cancer Research's Award for Outstanding Achievement in Cancer Research and the American Society of Hematology's Distinguished Service Award.
References[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
